Feasibility leverage Velocity recently launched Feasibility Agent leveraging longitudinal data from 70+ global sites to assess site suitability. This presents an opportunity to upsell feasibility services to biopharma sponsors aiming to accelerate trial planning and site selection in Europe and the US.

Europe expansion Ongoing European office growth and site acquisitions indicate an expanding footprint in a key market. Sales opportunities exist in compliant site networks, local CRO partnerships, and in supporting sponsors with multicountry trial execution.

Data and analytics The tech stack includes Power BI, Tableau, Salesforce, and Palantir collaboration, plus a dedicated data hub in India. This enables advanced trial analytics, performance dashboards, and data-driven feasibility that can be packaged as a value proposition for sponsors seeking insights-driven trials.

Leadership and credibility Strategic hires such as a Chief Revenue Officer and high-profile leadership transitions, along with industry events and executive-level dinners, strengthen market credibility. This opens conversations with senior sponsors about strategic partnerships and preferred provider status.

Integrated site network With 70+ sites, 200+ investigators, and unified site solutions across the US and Europe, Velocity can offer consolidated trial management, standardized processes, and end‑to‑end site support to reduce cycle times and improve enrollment efficiency for potential clients.